Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease

Area of Science:

• Immunology
• Oncology
• Cardiovascular Science

Background:

• Immune modulation is key in cancer and atherosclerosis treatment.
• Anti-inflammatory therapies pose a dilemma for cancer survivors, potentially increasing cancer risk while reducing cardiovascular risk.
• Cellular senescence is linked to cancer therapy resistance and vascular disease progression.

Purpose of the Study:

• To review the long-term impact of cancer therapies on vascular health.
• To highlight the role of senescence in cancer survivorship and vascular disease.
• To emphasize exercise as a strategy to mitigate senescence and its negative effects.

Main Methods:

• Literature review focusing on cancer therapies, vascular health, and senescence.
• Analysis of the dual role of immune modulation in cancer and vascular disease.
• Exploration of exercise's potential to delay senescence.

Main Results:

• Cancer therapies can negatively affect vascular health.
• Senescence exacerbates risks associated with cancer treatment and vascular disease.
• Exercise may delay senescence, potentially improving cancer survivorship and reducing vascular disease risk.

Conclusions:

• Modulating senescence is crucial for balancing cancer treatment efficacy and vascular impact.
• Exercise-mediated suppression of senescence offers a promising avenue for improving cancer survivorship.
• Further research is needed on exercise interventions for cancer survivors to manage senescence-related risks.